Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [757]

Oncolytic immunotherapeutic virus shows promise in liver cancer

Oncolytic immunotherapeutic virus shows promise in liver cancer

Genetically engineered virus extends the lives of terminally-ill liver cancer patients

Genetically engineered virus extends the lives of terminally-ill liver cancer patients

Most NCDs could be treated with small number of cheap generic drugs and within existing budgets

Most NCDs could be treated with small number of cheap generic drugs and within existing budgets

Engineered oncolytic herpes virus inhibits ovarian and breast cancer metastases

Engineered oncolytic herpes virus inhibits ovarian and breast cancer metastases

HPV associated cancer incidence rates point to needed efforts to increase HPV vaccination coverage

HPV associated cancer incidence rates point to needed efforts to increase HPV vaccination coverage

Positive early results in clinical trial for DNA vaccine

Positive early results in clinical trial for DNA vaccine

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

Oropharyngeal cancer patients with HPV have a more robust response to radiation therapy

Oropharyngeal cancer patients with HPV have a more robust response to radiation therapy

New study confirms erroneous link between XMRV and prostate cancer-contamination was the cause

New study confirms erroneous link between XMRV and prostate cancer-contamination was the cause

Assessment of HPV DNA alone insufficient to identify HPV-driven head and neck cancers

Assessment of HPV DNA alone insufficient to identify HPV-driven head and neck cancers

More from ecancer